Immunoreactive plasma fibronectin depletion has been associated with the presence of collagen-fibronectin complexes in patients after trauma and in animal models of traumatic and burn injuries. However, the role of plasma fibronectin in the development of sepsis after traumatic and burn injuries in patients is unknown. Treatment of patients and animals with purified human plasma fibronectin ameliorates some of the clinical and metabolic effects of systemic endotoxemia. We report that the induction of immunoreactive plasma fibronectin deficiency by gelatin infusion is associated with enhanced effects of intraperitoneal Escherichia coli endotoxin injection. We have observed a significant increase in the concentrations of ammonia in plasma of treated rats compared with those in control rats administered the same dose of endotoxin.
Bacterial sepsis and its attendant complications continue to result in major morbidity and increased mortality in hospitalized patients recovering from traumatic injury, burns, and surgical wounds (17) . Numerous studies have documented the detrimental effects of accidental or surgical trauma on host defense mechanisms, such as subnormal leukocyte function, cutaneous anerLy, and depressed function of tissue macrophages belonging to the mononuclear phagocyte system (MPS) (1) . Depression of MPS phagocytic activity correlates with the severity of injury in these patients and may be the greatest risk factor for the development of endotoxemia during gram-negative infections (2, 3, 14) . Fibronectin is a high-molecular-weight glycoprotein which appears to play a critical role in MPS clearance of autologous tissue debris, immune complexes, and bacteria. The concentrations of this glycoprotein in plasma may be decreased (by 40% or more) in patients after traumatic, burn, and surgical wounds (12, 15) .
Recently, Everett et al. (5) reported that pretreatment of anesthetized dogs with purified human plasma fibronectin significantly ameliorated the effects of a lethal injection of Escherichia coli endotoxin on several clinically relevant cardiovascular, acid-base, and metabolic parameters. Saba et al. (12, 13) have reported that the infusion of fibronectinrich cryoprecipitates in septic adult trauma and surgical patients increases the fibronectin concentration in plasma and is associated with clinical improvement. We have previously utilized a model of sublethal endotoxin administration to elucidate alterations in metabolism induced by endotoxemia in the rat (19) and have reported that impaired hepatic nitrogen metabolism with elevations in the concentrations of ammonia and urea in plasma is an early effect of endotoxin administration (9) . Since fibronectin depletion has been associated with an increased risk of sepsis in burn patients and plasma fibronectin pretreatment reduces some of the effects of endotoxemia in animals, we hypothesized that transient plasma fibronectin deficiency might lead to enhanced endotoxin effects in our sublethal endotoxemic model. In this report, we compare the differences in the ammonia concentrations in plasma of endotoxin-challenged normal and plasma fibronectin-deficient rats.
Immunoreactive plasma fibronectin deficiency was induced by intravenous infusion of gelatin (denatured collagen). This technique has been shown by Deno et al. (3) to result in transient plasma fibronectin depletion, apparently through clearance of the gelatin-fibronectin complex by the liver. Briefly, 0.1 ml of blood was collected in EDTA-coated tubes from the tail vein of 20 250-to 300-g male SpragueDawley rats (Charles River Breeding Laboratories, Wilmington, Mass.) for base-line determinations of plasma fibronectin. Animals (n = 10 for each group) were intravenously injected with a placebo (5% glucose in water) or 12 mg of gelatin (ICN Biochemicals Inc., Cleveland, Ohio) per kg of body weight (BW). Since endotoxin administration has been reported to increase the fibronectin concentration in plasma of the rat (11), we also quantified the fibronectin concentration in plasma of animals that were pretreated with placebo or gelatin and that then received 0.2 mg of E. coli O111:B4 endotoxin (phenol preparation from Sigma Chemical Co., St. Louis, Mo.) per kg of BW or 5% glucose in water intraperitoneally (Table 1) . We previously determined (9) Gelatin infusion resulted in a significant reduction in the fibronectin concentrations in plasma at 1 (40%), 2 (30%), and 4 (22%) h compared with those of control animals receiving a placebo injection ( Table 1 ). The fibronectin concentration is plasma returned to normal 12 h after gelatin administration. To ascertain the effect of fibronectin depletion and endotoxin administration on ammonia concentrations in plasma, two groups (n = 20 for each group) of rats were studied. All animals had a blood sample taken for a base-line determination of the ammonia concentration in plasma, after which they received either an intravenous placebo or gelatin injection (12 mg/kg of BW). One hour later, control animals (n = 10) received an intraperitoneal injection of 5% glucose in water, whereas study animals were injected with E. coli O111:B4 endotoxin (0.2 mg/kg of BW). All rats were bled 12 h later for a final determination of the ammonia concentration in plasma. We had previously determined that ammonia and urea concentrations in plasma and in the liver are increased by 4 h but that significant increases in the ammonia concentrations in plasma are not observed until 12 h after endotoxin administration (9) . For determination of each ammonia concentration in plasma, 0.5 ml of heparinized whole blood was obtained from the tail vein and centrifuged, and the plasma was quickly mixed with cold perchloric acid (final concentration, 4%). This mixture was centrifuged, and the clear supernatant was neutralized with 2 N K2CO3-0.58 M triethanolamine for plasma ammonia quantitation by the method of Gutmann and Bergmeyer (6) .
The base-line ammonia concentration in plasma of control animals (62 ± 18 FLM) was not significantly increased 12 h after placebo administration (84 ± 28 ,uM). Gelatin infusion had no effect on ammonia concentrations in plasma (86 ± 18 ,uM), but endotoxin administration resulted in a significant, 48% increase in ammonia concentrations in plasma (125 + 21 ,uM). If animals were rendered plasma fibronectin deficient by gelatin infusion before endotoxin administration, a considerably larger and significant, 101% increase in ammonia concentrations in plasma was observed (169 ± 44 FM).
To determine whether the greater increase in ammonia concentrations in plasma was related to plasma fibronectin deficiency or was a nonspecific consequence of MPS blockade by increased amounts of circulating colloidal protein, we performed an additional experiment. Ten rats were intravenously injected with colloidal human serum albumin (12 mg/kg of BW) which had been prepared by heat aggregation (16) , and then five were intraperitoneally injected with endotoxin (0.2 mg/kg of BW) or 5% glucose in water. Fibronectin concentrations in plasma were determined at base line and at 1, 2, 4, and 12 h, and ammonia concentrations were determined at base line and 12 h. Colloidal albumin administration did not change fibronectin concentrations in plasma compared with those of control animals at any time (data not shown). Injection of colloidal albumin before endotoxin administration did result in a 51 + 8% increase from the base line in ammonia concentrations in plasma; however, the change was comparable to the placebo and endotoxin administration increase of 48 ± 9%. Thus, MPS challenge with a colloidal protein whose clearance is not dependent on plasma fibronectin does not modify the effect of endotoxin on ammonia concentrations in plasma.
From the preceding experiments, it appeared that either a decrease in the immunoreactive fibronectin concentration in plasma or the presence of a fibronectin-gelatin complex was associated with an enhanced effect of endotoxin on ammonia concentrations in plasma. To determine if this effect could be modified, we intravenously injected animals (n = 6) with gelatin (12 mg/kg of BW) which had been preincubated (37°C for 30 min) with opsonically active purified human plasma fibronectin (New York Blood Center, New York), and fibronectin concentrations in plasma were determined at base line and at 1, 2, and 4 h. Human plasma fibronectin was utilized since it is readily available and previous studies have shown that human and animal fibronectins show similar patterns of specificity and affinity for native and denatured collagen (4) . A quantity of plasma fibronectin (200 jig/ml) calculated to interact with 50% of the gelatin binding sites for fibronectin was added to gelatin in vitro (7) . Fibronectin concentrations in plasma decreased by 28 + 8, 13 ± 15, and 7 ± 4% at 1, 2, and 4 h, respectively, after infusion of the gelatin-fibronectin complex. At 1 h, this percent decrease was significantly less than that from rats given gelatin alone but greater than that obtained from control animals at 1 h.
Six additional rats received the gelatin-fibronectin complex intravenously, followed by endotoxin (0.2 mg/kg of BW) intraperitoneally. Whereas gelatin infusion before endotoxin administration resulted in a 101% increase in the ammonia concentration in plasma compared with that of placebotreated rats, infusion of the gelatin-fibronectin complex before endotoxin injection resulted in a smaller, 44 + 7% increment in the ammonia concentration in plasma, nearly equivalent to the 48% increment in the ammonia concentration in plasma measured in animals given endotoxin alone compared with that in placebo-treated animals.
To further clarify the relationship between the fibronectin concentration in plasma and endotoxin impairment of nitrogen metabolism in the rat, we pretreated five rats intravenously with sufficient purified human plasma fibronectin to theoretically raise the fibronectin concentrations in plasma by 200 ,ug/ml (a value equivalent to the decline in plasma fibronectin seen in gelatin-treated rats). An additional five rats received a placebo injection intravenously, and then both groups were injected intraperitoneally with endotoxin (0.2 mg/kg). Since ammonia and urea concentrations in plasma are similarly raised after endotoxin administration (9), we measured urea (6) 12 h after endotoxin administration in these animals. Placebo-pretreated animals were found to have urea concentrations of 5.98 ± 0.31 mM in plasma, whereas fibronectin-pretreated animals had significantly lower urea concentrations of 3.70 ± 1.27 mM in plasma. The urea concentrations in plasma of the fibronectin-pretreated animals were nearly equivalent to the urea concentrations (3.56 ± 0.37 mM) in plasma of normal fasted rats (9) , suggesting that fibronectin infusion may have blunted the effect of endotoxin on nitrogen metabolism in these animals.
The mechanism of gelatin-induced immunoreactive plasma fibronectin depletion is not well understood. Plasma fibronectin expresses a specific collagen binding site (2) but binds more avidly to denatured collagen (gelatin) than to native collagen (4). Ingham et al. (7) reported that the addition of gelatin to plasma fibronectin in vitro results in the formation of a high-molecular-weight fibronectin-gelatin complex. Recently, a high-molecular-mass (1,000-kilodalton) collagen-fibronectin complex was isolated from the plasma of patients after aortic surgery (10) . The We also gratefully thank Carol Blue for her assistance in the preparation of this manuscript.
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